Optimizing the Start Time of Biologics in Polyarticular Juvenile Idiopathic Arthritis: A Comparative Effectiveness Study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment…

Overview of attention for article published in Arthritis & Rheumatology, September 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 5 news outlets
twitter: 18 X users

guideline: 1 clinical guideline source

Readers on

mendeley: 58 Mendeley

So far, Altmetric has seen 5 news stories from 5 outlets.

Early initiation of biologics appears best strategy in JIA

Thelimbic, 21 Nov 2022

Professor Yukiko Kimura Early combination therapy – csDMARD and bDMARD started together – appears the best treatment strategy…

Drug combo at outset of polyarticular JIA benefits patients most

Pediatric News , 10 Nov 2021

Initiating treatment of polyarticular juvenile idiopathic arthritis (polyJIA) with both a conventional synthetic disease-modifyin…

Drug Combo at Outset of Polyarticular JIA Benefits Patients Most

Medscape, 10 Nov 2021

Initiating treatment of polyarticular juvenile idiopathic arthritis (polyJIA) with both a conventional synthetic disease-modifyin…

Early Biologics Better in Juvenile Idiopathic Arthritis

MedPage Today, 08 Nov 2021

Meeting Coverage > ACR After 2 years, more patients on combo biologic/DMARD regimen had inactive disease by Nancy Walsh…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 1 additional news stories.